Targeted therapies and adverse drug reactions in oncology: the role of clinical pharmacist in pharmacovigilance

Background The majority of adverse drug reactions (ADRs) reported in the summary of product characteristics (SPCs) are based on pivotal clinical trials, performed under controlled conditions and with selected patients. Objectives (1) to observe ADRs in the real-world setting and to evaluate if the s...

Full description

Saved in:
Bibliographic Details
Published in:Int J Clin Pharm
Main Authors: Fornasier, G., Taborelli, M., Francescon, S., Polesel, J., Aliberti, M., De Paoli, P., Baldo, P.
Format: Artigo
Language:Inglês
Published: Springer International Publishing 2018
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6132980/
https://ncbi.nlm.nih.gov/pubmed/29785683
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11096-018-0653-5
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items